Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Loss of Chromosome Y Associates With Altered Immune Cell Trajectories and X-Inactivation Features.
PMID 42070154 · PMC13135724 · Aging cell · 2026 · 8 claims · 5 setups
LOY has cell type-specific effects on immune cells, with the highest prevalence in classical monocytes, that vary along differentiation trajectories
-
Full-text index only
Computational analysis of multi-omics data reveals CXCL10(+) DC-Treg interaction drives immunosuppressive microenvironment in AFP-positive hepatocellular carcinoma.
PMID 41854876 · PMC13038760 · Cellular and molecular life sciences : CMLS · 2026 · 8 claims · 8 setups
STMN1+ and AFP+ malignant cell subsets are enriched in AFP-positive HCC, while CYP3A4+ malignant cells are enriched in AFP-negative HCC
-
Full-text index only
Divergent macrophage-regulated T cell states determine response to Bacillus Calmette-Guérin vaccine in high-risk bladder cancer.
PMID 42081487 · PMC13262731 · The Journal of clinical investigation · 2026 · 8 claims · 8 setups
BCG responders show an increase in Th17-like Th1 CD4+ T cells with greater proinflammatory cytokine expression
-
Full-text index only
The landscape of responses to neoadjuvant immunotherapy in resectable Kirsten rat sarcoma viral oncogene homolog-mutant lung adenocarcinoma: Clinical heterogeneity and correlative immunologic analysis.
PMID 42011021 · PMC13096693 · Clinical and translational medicine · 2026 · 6 claims · 8 setups
KRAS-mutant LUAD patients show significantly poorer pathological response and inferior long-term survival after neoadjuvant immunotherapy compared to KRAS-wildtype patients
-
Full-text index only
Dissecting glioblastoma risk signatures in the tumor immune microenvironment based on multi-dimensional transcriptomics.
PMID 41880523 · PMC13154832 · GigaScience · 2026 · 7 claims · 8 setups
Hallmarks of malignancy and cell cycle regulatory pathways are consistently enriched across single-cell, bulk, and spatial transcriptomic modalities, promoting tumor cell proliferation and progression.